10-124461974-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_022126.4(LHPP):āc.112G>Cā(p.Glu38Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000156 in 1,219,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000092 ( 0 hom., cov: 32)
Exomes š: 0.0000047 ( 0 hom. )
Consequence
LHPP
NM_022126.4 missense
NM_022126.4 missense
Scores
1
7
11
Clinical Significance
Conservation
PhyloP100: 4.51
Genes affected
LHPP (HGNC:30042): (phospholysine phosphohistidine inorganic pyrophosphate phosphatase) Enables inorganic diphosphatase activity and protein homodimerization activity. Involved in phosphate-containing compound metabolic process. Located in cytosol and nuclear speck. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.29074305).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LHPP | NM_022126.4 | c.112G>C | p.Glu38Gln | missense_variant | 1/7 | ENST00000368842.10 | NP_071409.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LHPP | ENST00000368842.10 | c.112G>C | p.Glu38Gln | missense_variant | 1/7 | 1 | NM_022126.4 | ENSP00000357835.5 | ||
LHPP | ENST00000368839.1 | c.112G>C | p.Glu38Gln | missense_variant | 1/6 | 1 | ENSP00000357832.1 | |||
LHPP | ENST00000392757.8 | c.112G>C | p.Glu38Gln | missense_variant | 1/6 | 3 | ENSP00000376512.4 |
Frequencies
GnomAD3 genomes AF: 0.0000724 AC: 11AN: 151906Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
11
AN:
151906
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000468 AC: 5AN: 1067934Hom.: 0 Cov.: 33 AF XY: 0.00000396 AC XY: 2AN XY: 504520
GnomAD4 exome
AF:
AC:
5
AN:
1067934
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
504520
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000921 AC: 14AN: 152014Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74338
GnomAD4 genome
AF:
AC:
14
AN:
152014
Hom.:
Cov.:
32
AF XY:
AC XY:
8
AN XY:
74338
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3436
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 07, 2024 | The c.112G>C (p.E38Q) alteration is located in exon 1 (coding exon 1) of the LHPP gene. This alteration results from a G to C substitution at nucleotide position 112, causing the glutamic acid (E) at amino acid position 38 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M;M
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
N;N;N
REVEL
Benign
Sift
Uncertain
D;D;D
Sift4G
Benign
T;D;T
Polyphen
D;B;D
Vest4
MutPred
Gain of MoRF binding (P = 0.0395);Gain of MoRF binding (P = 0.0395);Gain of MoRF binding (P = 0.0395);
MVP
MPC
0.57
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at